Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: International community of women living with HIV-Kenya chapter
Street 1: P.o. box 343-00517, Nairobi
Street 2: P.o. box 343-00517, Nairobi
City: Nairobi
Province: 8 provincer and 47 county
Post Code: 00517
Country: Kenya
Phone: +254-0722758449
Organization Email: achiengdoro@gmail.com
Web Site: http:// www.icwea.org
Other Online Presence:

Focal Point Contact Information

Salutation: Ms
First Name: Dorothy
Last Name: odhiambo
Title: Patron
Email: achiengdoro@gmail.com
Phone: +254-0722758449

Alternate Focal Point Contact Information

Salutation: Ms
First Name: Rukia
Last Name: Ahmed farah
Title: National Executiver
Email: rukiawario@yahoo.com
Phone: +254-722767745

General Information

Board Constituency: Communities
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Patient Organization
Organization Type - Secondary: None
Organization Description:
International community of Women living with HIV-kenya chapter is a national advocacy network and membership based organization It is run by and for women living with HIV . ICW-kenya chapter exists to give visibility to women living with HIV in 47 county and believes that gender inequalities and the lack of sexual and reproductive health and rights for women are at the heart of the HIV epidemic.
We are interested in Tuberclosis because TB is not only the leading cause of morbidity and death to people living with HIV but it kills more women every year than any other infection and it is particularly lethal for women living with HIV.these women face the lethal combination of living with HIV and having poor access to health services, making them particularly vulnerable to poorer outcomes linked to undetected or late detected TB disease. While both the TB and HIV epidemics are considered to have a woman’s face, the women remain invisible when it comes to policy making processes, implementation, monitoring and evaluation of programs and services to effectively make a great contribution to the alleviating the burden of TB and HIV this is due to lack of adequate information on TB so as
We build the capacity of women living with HIV in the basic understanding of the TB basic science as TB Patience,the policy and its components so that they are able to engage in the policy implementation and hold the relevant policy makers accountable to ensuring quality and appropriate World TB Day,TB/HIV services are available We also aim at focusing on integrating TB in other areas such as reproductive health and maternal and child health services for women living with HIV.
 
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Advocacy
Delivery of health services and care
Funding, including innovative and optimized approach to funding TB Care
Provision of drugs, diagnostics and commodities
Research and Development
Technical Assistance

Other Organization Information

Total number of staff in your organization: 1 - 5
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 6 - 10
 
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: Uganda
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
The international community of women living with HIV-Kenya chapter-Aims at creating an environment in kenya where men and women are able to access services have opportunities and exercise their rights equally.Tuberculosis is an ancient disease that remains an important national cause of morbidity and mortality. In most cases, TB can be treated and cured by taking a combination of several drugs for 6 to 12 months. When inappropriate or incomplete treatment takes place, however, TB bacteria can develop resistance to multiple drugs. Treatment of drug-resistant TB is currently longer, more toxic, more complex, and less effective than for drug-susceptible TB. In 2011, less than 10% of the total estimated multidrug-resistant TB (MDR TB) cases were detected and annually, there are approximately 500,000 cases of MDR TB, and 150,000 deaths. Although there are simple rapid tests that have improved the diagnosis of the disease, there is immense potential to increase the number of persons diagnosed with MDR TB, and diagnose them more quickly so that they can begin treatment sooner.
Please join us as we discuss how more patients can benefit from advances in diagnostic and treatment options, resulting in an overall reduction in morbidity from MDR TB. This session of Grand Rounds will also explore the role of ICW-Kenya chapter is to mobilized women to hospital,CDC, WHO and other partners in combating this public health epidemic.
 

Geographical Reach

Which country is your headquarters located in: Kenya
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Kenya

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
The ICW-kenya chapter members with DOTS Expansion national Working Group (DENWG)is pleased to share with you the first issue of DEWNG Focus-our quarterly newsletter. aims to advocacy by creating an environment in kenya 47 county access TB servicess to all keep you abreast of DEWNG’s activities and facilitate the sharing of information, experiences and ideas on how to ensure equitable access to high-quality DOTS services for all women and children with TB. As we endeavor to communicate more regularly with you, our partners, supporters and stakeholders, we invite you to share your experiences, contact us for any enquirers, comments or further information. We look forward to stimulating a two-way dialogue.increasing women's leadership and participation in TB actives.

Drug-Resistant TB:
The ICW-kenya chapter members with DOTS Expansion national Working Group (DENWG)is pleased to share with you the first issue of DEWNG Focus-our quarterly newsletter. aims to advocacy by creating an environment in kenya 47 county access TB servicess to all keep you abreast of DEWNG’s activities and facilitate the sharing of information, experiences and ideas on how to ensure equitable access to high-quality DOTS services for all women and children with TB. As we endeavor to communicate more regularly with you, our partners, supporters and stakeholders, we invite you to share your experiences, contact us for any enquirers, comments or further information. We look forward to stimulating a two-way dialogue.increasing women's leadership and participation in TB actives.

TB-HIV:
The ICW-kenya chapter members with DOTS Expansion national Working Group (DENWG)is pleased to share with you the first issue of DEWNG Focus-our quarterly newsletter. aims to advocacy by creating an environment in kenya 47 county access TB servicess to all keep you abreast of DEWNG’s activities and facilitate the sharing of information, experiences and ideas on how to ensure equitable access to high-quality DOTS services for all women and children with TB. As we endeavor to communicate more regularly with you, our partners, supporters and stakeholders, we invite you to share your experiences, contact us for any enquirers, comments or further information. We look forward to stimulating a two-way dialogue.increasing women's leadership and participation in TB actives.

Laboratory Strengthening:
advocacy for more laboratory to be access easy

New Diagnostics:
lack of new diagonalize we would advocacy by create awareness and sensational community on diagnostics by used TB medical process

New TB Drugs:
advocacy for more laboratory to be access easy-she is a medical doctor, living positively with HIV. She is a treatment, gender and human rights activist for HIV positive women and is passionate about PLHIV and women’s sexual and reproductive health rights. Dr. Mungherera is the founder and co-founder of several organizations providing support to women in general and positive women in particular including the Athena Network, the Pan-African Coalition of Women Living with HIV and the Mama’s Club Uganda. The latter organization addresses the specific psychosocial needs and reproductive health rights of rural mothers living with HIV and was a recipient of the Red Ribbon Award at the International AIDS Conference in Mexico in 2008. More recently, she has been working on projects to improve the quality of women lives by mobilizing their partners, notably as a member of the Africa and Global Men Engage steering committees and by convening the Uganda Men Engage Network and Men Engage Consortium. At the international level, she has been contributing to the HIV counselling, prevention and treatment guidelines with UNAIDS and WHO as a civil society representative since 2003; she most recently reviewed the 2013 ARV treatment guidelines. In Uganda, she is a member of the National Maternal Child Health Cluster and PMTCT National Advisory Committee developing the Uganda PMTCT scale up plan and more recently, the National Task Force of the Option B+ implementation. Dr. Mungherera is a member of the Ugandan Health Policy Advisory Committee.


New TB Vaccines:
advocacy for more new TB vaccines with KAVI to be access easy TB vaccines for children and community

Fundamental Research:
lack of funding.write concert paper and proposal to Global stop TB

Research:
lack of research data for 47 county in kenya

Declaration

Declaration of interests:
we are interest to work together as a team leader to making in our community to all level

Application date: April 2, 2014
Last updated: May 12, 2014